Drug General Information
Drug ID
D09AYQ
Former ID
DNC003511
Drug Name
PIRITREXIM
Drug Type
Small molecular drug
Indication Bladder cancer [ICD9: 188; ICD10:C67] Phase 2 [521445], [542438]
Structure
Download
2D MOL

3D MOL

Formula
C17H19N5O2
InChI
InChI=1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22)
InChIKey
VJXSSYDSOJBUAV-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) DHFR Target Info Modulator
KEGG Pathway One carbon pool by folate
Folate biosynthesis
Metabolic pathways
PANTHER Pathway Tetrahydrofolate biosynthesis
Formyltetrahydroformate biosynthesis
Pathway Interaction Database E2F transcription factor network
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
WikiPathways Nucleotide Metabolism
Trans-sulfuration and one carbon metabolism
Retinoblastoma (RB) in Cancer
One Carbon Metabolism
Metabolism of water-soluble vitamins and cofactors
Metabolism of nitric oxide
Folate Metabolism
Fluoropyrimidine Activity
References
Ref 521445ClinicalTrials.gov (NCT00002914) Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract. U.S. National Institutes of Health.
Ref 542438(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7414).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.